Pfizer, Inc.
Long

PFE Pfizer to All Time High

604
If you haven`t bought at my first call, when PFE was $40:
PFE Pfizer short term Price Target


Than you should know that Pfizer’s vaccine with BioNTech SE is on track to be the best-selling drug product on a yearly basis and received backing from a European regulatory panel on Thursday to expand its use into children as young as five.

Still low PE Ratio (TTM) 15.42
Decent Forward Dividend & Yield 1.56 (2.89%)

The stock jumped also on the promise of its antiviral pill!

For me is a Buy even at this level!

Clause de non-responsabilité

Les informations et publications ne sont pas destinées à être, et ne constituent pas, des conseils ou recommandations financiers, d'investissement, de trading ou autres fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.